A joint University of Zurich-Ludwig Cancer Research study has demonstrated that combining an existing cancer drug with a dietary intervention dramatically improves the efficacy of the therapy and greatly extends survival time in mouse models of neuroblastoma, a frequently lethal pediatric cancer.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
